PeptaHub
The comprehensive peptide reference

Peptide guides

EDUCATIONAL ARTICLES37 GUIDES · 257 SECTIONS

Comprehensive peptide education — what they are, how they work, safety profiles, legal status, and research context.

Overview
37
Guides
257
Sections
220
FAQs answered
107
Peptides referenced

Evidence-based educational content covering peptide science, safety, legal status, and research context. Sourced from peer-reviewed research and clinical literature.

All guidesJump →
01What Are Peptides? A Complete Introduction8 SECTIONS→02How Do Peptides Work? Mechanisms Explained8 SECTIONS→03Are Peptides Safe? Risks, Side Effects & What the Research Says8 SECTIONS→04Peptides for Beginners: Where to Start8 SECTIONS→05Peptide Legal Status: What's Legal, Prescription, and Banned8 SECTIONS→06Peptide Safety Guide: Side Effects, Risks & Protocols8 SECTIONS→07How to Reconstitute Peptides: Dosing Math, Protocol & Storage7 SECTIONS→08Cardiovascular Peptides: A Guide to Antithrombotics, Natriuretic Peptides, and RAAS Peptides7 SECTIONS→09Gut Hormones: A Guide to Motilin, Secretin, PYY, GIP, Nesfatin-1, and Glucagon8 SECTIONS→10Antimicrobial Peptides: A Guide to Cathelicidins, Defensins, Magainin, and Clinical AMPs9 SECTIONS→11GnRH Analogs: A Guide to Agonists, Antagonists, and Clinical Uses7 SECTIONS→12Endogenous Opioid Peptides: A Guide to Dermorphin, Deltorphin, Kyotorphin, Nociceptin, and MIF-17 SECTIONS→13Thymic Peptides: A Guide to Thymopentin, Thymopoietin, Thymulin, and Thymus Extract7 SECTIONS→14Pain Peptides: A Guide to Substance P, Bradykinin, CGRP, Ziconotide, and Galanin7 SECTIONS→15Amylin Analogs: A Guide to Pramlintide, Cagrilintide, and the Amylin-GLP-1 Axis7 SECTIONS→16Collagen Peptide Types: Type I, II, III, and Hydrolysate Dipeptides Compared7 SECTIONS→17Peptide Therapeutics in Oncology: Proteasome Inhibitors, HDAC Inhibitors, and Beyond8 SECTIONS→18Somatostatin Analogs: A Guide to Somatostatin, Cortistatin, and SSTR Pharmacology6 SECTIONS→19Nootropic Peptides: Semax Variants, Selank, Dihexa, and Cerebrolysin Compared6 SECTIONS→20The Melanocortin System: α-MSH, NPY, Galanin, and Melanocortin-Receptor Pharmacology6 SECTIONS→21Reading a Peptide COA & Evaluating Supplier Quality9 SECTIONS→22GHK-Cu (Copper Peptide): Evidence, Mechanisms & Regulatory Status7 SECTIONS→23Retatrutide: Evidence, Mechanism & Trial Status7 SECTIONS→24Tirzepatide: Evidence, Mechanism & Approved Uses7 SECTIONS→25Semaglutide: Evidence, Mechanism & Approved Uses7 SECTIONS→26FDA Peptide Tracker 20263 SECTIONS→27Semaglutide vs Tirzepatide vs Retatrutide: 3-Way GLP-1 Comparison5 SECTIONS→28How PeptaHub Grades Peptide Evidence5 SECTIONS→29How Long Does BPC-157 Take to Work? An Evidence-Graded Timeline6 SECTIONS→30BPC-157 Oral vs Injection: What the Evidence Actually Shows6 SECTIONS→31GLP-1 Side Effects Week by Week: The Titration Ladder Timeline7 SECTIONS→32Switching From Semaglutide to Tirzepatide: The Evidence Guide6 SECTIONS→33CagriSema FDA Approval Tracker: Timeline, Status, What's Next6 SECTIONS→34Compounded GLP-1s in 2026: Legal Status, FDA Actions Explained8 SECTIONS→35Creatine on GLP-1s: What the Evidence Actually Shows8 SECTIONS→36CagriSema Reconstitution: The Math Without a Label7 SECTIONS→37What to Stack With BPC-157? An Evidence-Graded Answer6 SECTIONS→
All guides
37 ARTICLES
01
What Are Peptides? A Complete Introduction
The Basics: Amino Acids, Peptide Bonds, and Molecular Structure · Peptides vs. Proteins: What Is the Difference? · Natural Peptides: What the Body Already Produces
8 sections
→
02
How Do Peptides Work? Mechanisms Explained
Receptor Binding: How Peptides Communicate with Cells · The GLP-1 Pathway: Appetite, Blood Sugar, and Beyond · The Growth Hormone Axis: Secretagogues and the Pituitary
8 sections
→
03
Are Peptides Safe? Risks, Side Effects & What the Research Says
Understanding Evidence Levels: Clinical Trials vs. Animal Studies · FDA-Approved Peptide Drugs: Known Side Effects · Research Peptides: What We Know and What We Do Not Know
8 sections
→
04
Peptides for Beginners: Where to Start
The Major Peptide Categories: A Map of the Landscape · How to Evaluate Evidence: The Beginner's Framework · Understanding Dosing: Basics for Beginners
8 sections
→
05
Peptide Legal Status: What's Legal, Prescription, and Banned
The Regulatory Framework: How Peptides Are Classified · Tier One: FDA-Approved Peptide Drugs · Tier Two: Compounding Pharmacy Peptides
8 sections
→
06
Peptide Safety Guide: Side Effects, Risks & Protocols
General Safety Principles: The Framework Before the Details · Side Effects by Peptide Class: GLP-1 Receptor Agonists · Side Effects by Peptide Class: Growth Hormone Secretagogues
8 sections
→
07
How to Reconstitute Peptides: Dosing Math, Protocol & Storage
Supplies You Need Before You Start · The Math: Concentrations, Units, and Dose Calculations · The Physical Reconstitution Procedure
7 sections
→
08
Cardiovascular Peptides: A Guide to Antithrombotics, Natriuretic Peptides, and RAAS Peptides
Peptides in cardiovascular medicine: where they fit · Antithrombotics — direct thrombin inhibitors (bivalirudin) · Anti-platelet peptides — GPIIb/IIIa antagonists (eptifibatide, RGDS)
7 sections
→
09
Gut Hormones: A Guide to Motilin, Secretin, PYY, GIP, Nesfatin-1, and Glucagon
Gut-brain axis intro — why gut hormones matter · Motilin — Phase III MMC contractions and the erythromycin connection · Secretin — the first hormone ever discovered (Bayliss & Starling, 1902)
8 sections
→
10
Antimicrobial Peptides: A Guide to Cathelicidins, Defensins, Magainin, and Clinical AMPs
Why AMPs matter — the antimicrobial resistance crisis · Mechanism — membrane disruption and how AMPs kill bacteria · Cathelicidins and LL-37 (human AMP family)
9 sections
→
11
GnRH Analogs: A Guide to Agonists, Antagonists, and Clinical Uses
GnRH biology — hypothalamic pulsatility and LH/FSH regulation · Agonists — flare then suppression (leuprolide, buserelin, histrelin, nafarelin, alarelin) · Antagonists — immediate suppression (cetrorelix, ganirelix)
7 sections
→
12
Endogenous Opioid Peptides: A Guide to Dermorphin, Deltorphin, Kyotorphin, Nociceptin, and MIF-1
Opioid Receptor Primer: μ, δ, κ, and NOP · Dermorphin: A μ-Selective Heptapeptide From Frog Skin · Deltorphin: A δ-Selective Peptide From the Same Frog Family
7 sections
→
13
Thymic Peptides: A Guide to Thymopentin, Thymopoietin, Thymulin, and Thymus Extract
Thymic Biology: T-Cell Maturation and Immunosenescence · Thymopoietin: The 49-Amino-Acid Parent Protein · Thymopentin (TP-5): The Five-Amino-Acid Active Fragment
7 sections
→
14
Pain Peptides: A Guide to Substance P, Bradykinin, CGRP, Ziconotide, and Galanin
Peptides in Pain Pathways: Nociceptors to Supraspinal Modulation · Substance P and the NK1 Receptor · Bradykinin and the B2 Receptor
7 sections
→
15
Amylin Analogs: A Guide to Pramlintide, Cagrilintide, and the Amylin-GLP-1 Axis
Amylin Biology: A Second Beta-Cell Hormone · Pramlintide (Symlin): The First Amylin Analog · Cagrilintide: A Long-Acting Weekly Amylin Analog
7 sections
→
16
Collagen Peptide Types: Type I, II, III, and Hydrolysate Dipeptides Compared
Collagen Types Primer: 28 Types Known, 3 That Matter Most · Type I — Skin, Bone, Tendon: The Structural Collagen · Type II — Articular Cartilage and the Undenatured UC-II Mechanism
7 sections
→
17
Peptide Therapeutics in Oncology: Proteasome Inhibitors, HDAC Inhibitors, and Beyond
Peptide Therapeutics in Oncology: Where Peptides Fit · Proteasome Inhibitors: Bortezomib and Carfilzomib for Multiple Myeloma · HDAC Inhibitors: Romidepsin for Cutaneous T-Cell Lymphoma
8 sections
→
18
Somatostatin Analogs: A Guide to Somatostatin, Cortistatin, and SSTR Pharmacology
Somatostatin Biology: Hypothalamic Inhibitory Hormone · SSTR1-5 Receptor Subtypes and Tissue Distribution · Cortistatin: Structural Homolog with Distinct Biology
6 sections
→
19
Nootropic Peptides: Semax Variants, Selank, Dihexa, and Cerebrolysin Compared
Nootropic Peptide Landscape: Mostly Russian-Origin, Limited Western Trials · Semax Family: Parent Molecule, Semax 4-7, and N-Acetyl Variants · Selank: Anxiolytic Heptapeptide and GABA Modulation
6 sections
→
20
The Melanocortin System: α-MSH, NPY, Galanin, and Melanocortin-Receptor Pharmacology
Melanocortin System Primer: MC1R-MC5R, POMC, α/β/γ-MSH · α-MSH Biology: Pigmentation, Appetite, Inflammation · POMC and the Melanocortin Precursor Protein
6 sections
→
21
Reading a Peptide COA & Evaluating Supplier Quality
What a COA is — and what it isn't · HPLC purity — what the percentage actually means · Mass spectrometry — confirming molecular identity
9 sections
→
22
GHK-Cu (Copper Peptide): Evidence, Mechanisms & Regulatory Status
What GHK-Cu is — structure and natural occurrence · Mechanisms of action — what the evidence supports · Topical and cosmetic evidence — the strongest evidence base
7 sections
→
23
Retatrutide: Evidence, Mechanism & Trial Status
What retatrutide is and where it stands in 2026 · Mechanism of action: what each receptor does · Phase 2 evidence: weight loss and metabolic outcomes
7 sections
→
24
Tirzepatide: Evidence, Mechanism & Approved Uses
Regulatory Status: What Tirzepatide Is Actually Approved For · Mechanism of Action: The Dual GIP/GLP-1 Design · Approved Indication 1: Type 2 Diabetes — SURPASS Trial Evidence
7 sections
→
25
Semaglutide: Evidence, Mechanism & Approved Uses
What Semaglutide Is and How It Is Structured · Mechanism of Action: From Receptor to Effect · Approved Indications and the Evidence Behind Each
7 sections
→
26
FDA Peptide Tracker 2026
How to read this tracker · Tracker maintenance policy · Editorial caution
3 sections
→
27
Semaglutide vs Tirzepatide vs Retatrutide: 3-Way GLP-1 Comparison
Bottom line: which one is strongest on evidence today? · Why mechanism matters: one receptor, two receptors, three receptors · Weight-loss numbers: useful signal, imperfect comparison
5 sections
→
28
How PeptaHub Grades Peptide Evidence
The four evidence labels used on PeptaHub · Why study type matters · Endpoint quality: surrogate markers vs real outcomes
5 sections
→
29
How Long Does BPC-157 Take to Work? An Evidence-Graded Timeline
Why every BPC-157 timeline you can find online is anecdote · What the rat studies actually measured, and when · Why rodent timelines cannot be extrapolated to humans
6 sections
→
30
BPC-157 Oral vs Injection: What the Evidence Actually Shows
The scientific basis of the oral BPC-157 market · The only formal pharmacokinetic study, and what it does not contain · Subcutaneous vs intramuscular, and the inject-near-the-injury belief
6 sections
→
31
GLP-1 Side Effects Week by Week: The Titration Ladder Timeline
Why generic week-by-week guides mislead: dose weeks are not calendar weeks · The two titration ladders, exactly as the labels define them · What the trials actually report at each step
7 sections
→
32
Switching From Semaglutide to Tirzepatide: The Evidence Guide
Why people switch: the SURMOUNT-5 head-to-head numbers · Why there is no dose conversion chart · The switch protocol as the sources describe it
6 sections
→
33
CagriSema FDA Approval Tracker: Timeline, Status, What's Next
What CagriSema is, and why it has a tracker · The regulatory timeline, date by date · What we're watching
6 sections
→
34
Compounded GLP-1s in 2026: Legal Status, FDA Actions Explained
What "compounded GLP-1" actually means · Why compounded GLP-1s existed: the shortage era · What changed in 2025: shortage end and expired grace periods
8 sections
→
35
Creatine on GLP-1s: What the Evidence Actually Shows
The real question underneath: how much muscle comes off with the weight · What creatine actually is, in plain terms · The April 2026 paper: a proposal, not a trial
8 sections
→
36
CagriSema Reconstitution: The Math Without a Label
What CagriSema is — a co-formulated product, not a mixing recipe · Why no official reconstitution spec exists — and cannot yet · The dilution math, part one: research-grade cagrilintide
7 sections
→
37
What to Stack With BPC-157? An Evidence-Graded Answer
Why every 'what to stack with BPC-157' answer online is a product list · BPC-157 + TB-500: the Wolverine stack meets its first combined study · Adding GHK-Cu: the extracellular-matrix argument
6 sections
→

Education is the foundation of responsible peptide use — these guides exist to replace rumor with referenced, reviewable evidence.

— THE EDITORS